The EPA has revised its assessment of the health risks posed by the carcinogen, less than a year after the Biden administration issued its own verdict.
A new study finds a possible association between GLP-1 drugs like semaglutide and chronic cough, though the authors are calling for more research.
Outside experts and groups widely condemned the decision.
Bad news for people with peanut allergies.
New research finds the shingles vaccine can potentially provide broad protection against dementia.
The topical medication, called Clascoterone, could represent the first truly novel drug for male pattern baldness seen in about 30 years.
While investigating the dentist drill's anxiety-inducing high-pitched whine, researchers revealed why it's worse for children than adults.
Researchers used face masks and an airplane air filter to find out what microbes are floating around.
Kirk Milhoan has claimed without evidence that the covid-19 shots caused spikes in cancer and miscarriages. Now he's helping shape the country's vaccine policy.
The bed's smart monitoring alerted the man to a life-threatening heart condition, according to his doctor.
Research shows that antibacterial doses of "Miracle Mineral Solution" are likely harmful to the people taking it.
It's "becoming a more routine part of emergency medicine in the U.S."
CDC data indicates that norovirus is back on the warpath and getting plenty of Americans sick.
Over 41,000 bottles have been recalled.
New research shows a worrying connection between untreated apnea and a well-known neurodegenerative disorder.
A staff member at a Buddhist temple heard a knock while explaining to a relative how to get a death certificate.
At least 29 cases of equine herpes myeloencephalopathy have been detected in seven states so far.
An oral version of the GLP-1 drug semaglutide failed to significantly slow the disease's progression compared to a placebo.
At a recent event this week, the health secretary speculated that aluminum in vaccines is causing children's peanut allergies.
Risk factors for epilepsy, like poor sleep, might be more common in certain regions of the U.S., researchers say.
